Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

The atypical receptor CCRL2 is essential for lung cancer immune surveillance.

Del Prete A, Sozio F, Schioppa T, Ponzetta A, Vermi W, Calza S, Bugatti M, Salvi V, Bernardini G, Benvenuti F, Vecchi A, Bottazzi B, Mantovani A, Sozzani S.

Cancer Immunol Res. 2019 Sep 4. pii: canimm.0168.2019. doi: 10.1158/2326-6066.CIR-19-0168. [Epub ahead of print]

PMID:
31484658
2.

Pulmonary lymphatic vessel morphology: a review.

Weber E, Sozio F, Borghini A, Sestini P, Renzoni E.

Ann Anat. 2018 Jul;218:110-117. doi: 10.1016/j.aanat.2018.02.011. Epub 2018 Apr 19. Review.

PMID:
29679722
3.

Chemokine and chemotactic signals in dendritic cell migration.

Tiberio L, Del Prete A, Schioppa T, Sozio F, Bosisio D, Sozzani S.

Cell Mol Immunol. 2018 Apr;15(4):346-352. doi: 10.1038/s41423-018-0005-3. Epub 2018 Mar 21. Review.

4.

Preliminary evaluation of the impact of a Web-based HIV testing programme in Abruzzo Region on the prevention of late HIV presentation and associated mortality.

Polilli E, Sozio F, Di Stefano P, Clerico L, Di Iorio G, Parruti G.

Int J Infect Dis. 2018 Apr;69:44-46. doi: 10.1016/j.ijid.2018.01.021. Epub 2018 Feb 2.

5.

The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damage.

Del Prete A, Martínez-Muñoz L, Mazzon C, Toffali L, Sozio F, Za L, Bosisio D, Gazzurelli L, Salvi V, Tiberio L, Liberati C, Scanziani E, Vecchi A, Laudanna C, Mellado M, Mantovani A, Sozzani S.

Blood. 2017 Sep 7;130(10):1223-1234. doi: 10.1182/blood-2017-04-777680. Epub 2017 Jul 25.

6.

Role of Atypical Chemokine Receptors in Microglial Activation and Polarization.

Salvi V, Sozio F, Sozzani S, Del Prete A.

Front Aging Neurosci. 2017 May 26;9:148. doi: 10.3389/fnagi.2017.00148. eCollection 2017. Review.

7.

Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort.

Maggi P, Bellacosa C, Leone A, Volpe A, Ricci ED, Ladisa N, Cicalini S, Grilli E, Viglietti R, Chirianni A, Bellazzi LI, Maserati R, Martinelli C, Corsi P, Celesia BM, Sozio F, Angarano G.

Atherosclerosis. 2017 Aug;263:398-404. doi: 10.1016/j.atherosclerosis.2017.05.004. Epub 2017 May 5.

PMID:
28522147
8.

Web-Based HIV Testing in Abruzzo, Italy: Analysis of 15-Month Activity Results.

Polilli E, Sozio F, Di Stefano P, Sciacca A, Ursini T, Paoloni M, Vecchiet J, Di Giammartino D, Sciotti MP, Grimaldi A, Cortesi V, Fazii P, Ricci E, D'Amario C, Ippolito G, Pippa L, Parruti G.

AIDS Patient Care STDS. 2016 Oct;30(10):471-475.

PMID:
27749107
9.

Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.

Raggi C, Correnti M, Sica A, Andersen JB, Cardinale V, Alvaro D, Chiorino G, Forti E, Glaser S, Alpini G, Destro A, Sozio F, Di Tommaso L, Roncalli M, Banales JM, Coulouarn C, Bujanda L, Torzilli G, Invernizzi P.

J Hepatol. 2017 Jan;66(1):102-115. doi: 10.1016/j.jhep.2016.08.012. Epub 2016 Sep 1.

10.

A Reduction Grade of Lipodystrophy and Limited Side Effects after HAART Regimen with Raltegravir, Lamivudine, Darunavir and Ritonavir in an HIV-1 Infected Patient after Six Years of Antiretroviral Therapy.

Degli Antoni A, Weimer LE, Fragola V, Giacometti A, Sozio F.

West Indian Med J. 2015 Jun;64(3):291-3. doi: 10.7727/wimj.2014.066. Epub 2015 Jul 14.

11.

Long-term Maraviroc Therapy and Limited Side Effects in an HIV-1 Experienced Patient: Six Years of Antiretroviral Observation.

Cirioni O, Weimer LE, Fragola V, Giacometti A, Sozio F.

West Indian Med J. 2014 Dec;63(7):785-7. doi: 10.7727/wimj.2014.068. Epub 2014 Aug 29. No abstract available.

12.

Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.

Mazzotta E, Ursini T, Agostinone A, Di Nicola AD, Polilli E, Sozio F, Vadini F, Pieri A, Trave F, De Francesco V, Capasso L, Borderi M, Manzoli L, Viale P, Parruti G.

AIDS Patient Care STDS. 2015 Apr;29(4):169-80. doi: 10.1089/apc.2014.0205. Epub 2015 Feb 18.

PMID:
25692868
13.

Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort.

Tontodonati M, Cenderello G, Celesia BM, Trezzi M, Ursini T, Costantini A, Marra D, Polilli E, Catalani C, Butini L, Sozio F, Mazzotta E, Sciacca A, Rizzardini G, Manzoli L, Cozzi-Lepri A, Parruti G.

Clinicoecon Outcomes Res. 2014 Dec 22;7:27-35. doi: 10.2147/CEOR.S69183. eCollection 2015.

14.

Epi-aortic lesions, pathologic FMD, endothelial activation and inflammatory markers in advanced naïve HIV-infected patients starting ART therapy.

Bellacosa C, Maggi P, Volpe A, Altizio S, Ladisa N, Cicalini S, Viglietti R, Chirianni A, Bellazzi L, Zanaboni D, Maserati R, Martinelli C, Corsi P, Sofia S, Celesia M, Sozio F, Abbrescia N, Angarano G.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19545. doi: 10.7448/IAS.17.4.19545. eCollection 2014.

15.

Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens.

Baroncelli S, Pirillo MF, Galluzzo CM, Antoni AD, Ladisa N, Francisci D, d'Ettorre G, Segala D, Vivarelli A, Sozio F, Cirioni O, Weimer LE, Fragola V, Parruti G, Floridia M.

AIDS Res Hum Retroviruses. 2015 Jan;31(1):71-7. doi: 10.1089/AID.2014.0060.

16.

Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens.

Baroncelli S, Villani P, Galluzzo CM, Cavalli A, Volpe A, Francisci D, Vivarelli A, Sozio F, Tedeschi S, Cirioni O, Sighinolfi L, Cusato M, Pirillo MF, Weimer LE, Fragola V, Parruti G, Regazzi M, Floridia M.

Ther Drug Monit. 2013 Dec;35(6):785-90. doi: 10.1097/FTD.0b013e31829ad690.

PMID:
24061444
17.

Psychological factors, including alexithymia, in the prediction of cardiovascular risk in HIV infected patients: results of a cohort study.

Parruti G, Vadini F, Sozio F, Mazzott E, Ursini T, Polill E, Di Stefano P, Tontodonati M, Verrocchio MC, Fulcheri M, Calella G, Santilli F, Manzoli L.

PLoS One. 2013;8(1):e54555. doi: 10.1371/journal.pone.0054555. Epub 2013 Jan 22.

18.

Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease.

Polilli E, Ursini T, Mazzotta E, Sozio F, Savini V, D'Antonio D, Barbato M, Consorte A, Parruti G.

Ann Clin Microbiol Antimicrob. 2012 Mar 11;11:6. doi: 10.1186/1476-0711-11-6.

19.

Morphometric analysis of intralobular, interlobular and pleural lymphatics in normal human lung.

Sozio F, Rossi A, Weber E, Abraham DJ, Nicholson AG, Wells AU, Renzoni EA, Sestini P.

J Anat. 2012 Apr;220(4):396-404. doi: 10.1111/j.1469-7580.2011.01473.x. Epub 2012 Jan 30.

20.

Tinea incognito Caused by Microsporum gypseum in a Patient with Advanced HIV Infection: A Case Report.

Polilli E, Fazii P, Ursini T, Fantini F, Di Masi F, Tontodonati M, Sozio F, Parruti G.

Case Rep Dermatol. 2011 Mar 4;3(1):55-9. doi: 10.1159/000326055.

21.

Rapidly progressive and fatal EBV-related encephalitis in a patient with advanced HIV-1 infection at presentation: a case report and review of the literature.

Polilli E, Sozio F, Mazzotta E, Consorte A, Di Masi F, Agostinone A, Tontodonati M, Cosentino L, Parruti G.

New Microbiol. 2010 Jul;33(3):275-80.

22.

Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy.

Parruti G, Tontodonati M, Rebuzzi C, Polilli E, Sozio F, Consorte A, Agostinone A, Di Masi F, Congedo G, D'Antonio D, Granchelli C, D'Amario C, Carunchio C, Pippa L, Manzoli L, Volpi A; VZV Pain Study Group.

BMC Med. 2010 Oct 11;8:58. doi: 10.1186/1741-7015-8-58.

23.

Rapid prediction of sustained virological response in patients chronically infected with HCV by evaluation of RNA decay 48h after the start of treatment with pegylated interferon and ribavirin.

Parruti G, Polilli E, Sozio F, Cento V, Pieri A, Di Masi F, Mercurio F, Tontodonati M, Mazzotta E, Ceccherini-Silberstein F, Manzoli L, Perno CF.

Antiviral Res. 2010 Oct;88(1):124-7. doi: 10.1016/j.antiviral.2010.08.003. Epub 2010 Aug 11.

PMID:
20708036
24.

Absence of lymphatic vessels in human dental pulp: a morphological study.

Gerli R, Secciani I, Sozio F, Rossi A, Weber E, Lorenzini G.

Eur J Oral Sci. 2010 Apr;118(2):110-7. doi: 10.1111/j.1600-0722.2010.00717.x.

PMID:
20486999
25.

Fatal reactivation of HBV and HDV during a long-lasting interruption of HAART in a patient co-infected with HIV, HCV, HBV and HDV.

Polilli E, Sozio F, Mazzotta E, Pieri A, Alterio L, Placido E, Agostinone A, Di Masi F, Tontodonati M, Consorte A, Cosentino L, Parruti G.

Infez Med. 2010 Mar;18(1):43-7.

26.

Efficacy and safety of a salvage regimen based on tipranavir, enfuvirtide and three nucleoside analogues in HIV1 infected patients with clinical progression: 96-week evaluation.

Sozio F, Polilli E, D'Annunzio M, Falconi L, Di Masi F, Tontodonati M, Cosentino L, Consorte A, Di Giammartino D, Parruti G.

Infez Med. 2009 Dec;17(4):228-35.

27.

Lymphatic and blood vessels in scleroderma skin, a morphometric analysis.

Rossi A, Sozio F, Sestini P, Renzoni EA, Khan K, Denton CP, Abraham DJ, Weber E.

Hum Pathol. 2010 Mar;41(3):366-74. doi: 10.1016/j.humpath.2009.08.009. Epub 2009 Dec 11.

28.

Sequential transmission and long-term persistence of an HIV strain partially resistant to protease inhibitors.

Polilli E, Di Masi F, Sozio F, Mazzotta E, Alterio L, Cosentino L, Clerico L, Perno CF, Parruti G.

New Microbiol. 2009 Apr;32(2):205-8.

29.

Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1-patient exposed to efavirenz for three weeks: a case report and review of the literature.

Polilli E, Parruti G, Cosentino L, Sozio F, Saracino A, Consorte A, Angarano G, Di Masi F, Mazzotta E, Fazii P.

J Med Case Rep. 2009 Sep 18;3:9132. doi: 10.4076/1752-1947-3-9132.

30.

Femoral prosthesis infection by Rhodotorula mucilaginosa.

Savini V, Sozio F, Catavitello C, Talia M, Manna A, Febbo F, Balbinot A, Di Bonaventura G, Piccolomini R, Parruti G, D'Antonio D.

J Clin Microbiol. 2008 Oct;46(10):3544-5. doi: 10.1128/JCM.00873-08. Epub 2008 Aug 27.

Supplemental Content

Support Center